- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0006237

About Lxir Medilabs Private Limited
Data last updated:
Lxir Medilabs Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2019PTC078734. Its GSTIN is 06AADCL8593R1ZJ (Haryana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lata Jindal and Jatin Jindal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 48 Mdc Scetor – 5, Panchkula, Haryana, India – 134109.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.32 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹5.48 Lakh (net margin 0.3%) and EBITDA of ₹81.66 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
As per MCA filings, the company has open charges of ₹6.55 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.
Lxir Medilabs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0006237). For more details, the company can be reached via its website lxir.co.in.
Company details
Recognitions & Rankings of Lxir Medilabs
Contact details
Lxir Medilabs Private Limited's registered office is in Panchkula, Haryana. Its website is lxir.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSCO 48 Mdc Scetor – 5, Panchkula, Haryana, India – 134109
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lxir Medilabs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lxir Medilabs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lxir Medilabs Private Limited, buy the company report.
Financials of Lxir Medilabs Private Limited
FY 2025 filings availableLxir Medilabs Private Limited reported revenue of ₹19.32 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over three years, including 20% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lxir Medilabs Private Limited, buy the company report.
Board of directors of Lxir Medilabs Private Limited
Lxir Medilabs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lata Jindal Also directs: Manfaith Healthcare Private Limited, Ismith Healthcare Private Limited, Mediday Healthcare Private Limited and 1 more | Director | 22 Feb 2019 | 7 Years 8 Months | Current |
| Jatin Jindal Also directs: Aurum Medicare Private Limited, Manfaith Healthcare Private Limited, Ismith Healthcare Private Limited and 1 more | Director | 22 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Lxir Medilabs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avlaan Pharmaceutical Private Limited | ₹19.36 Cr (FY 2024) | 28.0% | Chennai, Tamil Nadu, India | |||
| Medic Biologicals and Pharmaceuticals Private Limited | ₹19.33 Cr (FY 2025) | 26.0% | Thiruvananthapuram, Kerala, India | |||
| Lxir Medilabs Private Limitedthis company | ₹19.32 Cr (FY 2025) | ₹5.48 Lakh | 0.3% | 20.0% | Panchkula, Haryana, India | |
| Delius Pharmaceuticals Private Limited | ₹19.28 Cr (FY 2024) | 7.0% | New Delhi, Delhi, India | |||
| Anax Lifescience Private Limited | ₹19.25 Cr (FY 2024) | 9.0% | Ahmedabad, Gujarat, India | |||
| Curosis Healthcare Private Limited | ₹19.23 Cr (FY 2024) | 16.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Lxir Medilabs Private Limited, buy the company report.
Auditor
Lxir Medilabs Private Limited is audited by N K ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N K ASSOCIATES | FY 2023 | 009872N |
Shareholding
The shareholding of Lxir Medilabs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lxir Medilabs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2023 | 100821607 | Hdfc Bank Limited | ₹5 Lakh | Open | |
| 17 Oct 2022 | 100624395 | Hdfc Bank Limited | ₹6.5 Cr | Open |
To see the full charge records of Lxir Medilabs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Lxir Medilabs Private Limited has 4 court cases on record: 4 filed by Lxir Medilabs. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 3 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against Cosmic Pharma and 3 others | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against Karthikeya Pharmaceuticlas | Disposed |
To see the full case history of Lxir Medilabs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lxir Medilabs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lxir Medilabs has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCL8593R1ZJ | Haryana | Active | 16 Mar 2019 |
| 02AADCL8593R1ZR | Himachal Pradesh | Active | 30 May 2022 |
To see the full GST registrations and return filing status of Lxir Medilabs Private Limited, buy the company report.
Recent activity
Lxir Medilabs Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Jatin Jindal was appointed as Director on 22 Feb 2019.
Frequently asked questions
Lxir Medilabs is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2019 (7+ years old) and is registered under CIN U51909HR2019PTC078734.
Lxir Medilabs has 2 current directors:
- Lata Jindal - Director
- Jatin Jindal - Director
The latest financial statements of Lxir Medilabs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Lxir Medilabs is 06AADCL8593R1ZJ, registered in Haryana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AADCL8593R1ZR (Himachal Pradesh).
The CIN (Corporate Identification Number) of Lxir Medilabs is U51909HR2019PTC078734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lxir Medilabs has 4 court cases on record: 4 filed by the company. 3 are pending.
Lxir Medilabs was incorporated on 22 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Lxir Medilabs by revenue are Avlaan Pharmaceutical Private Limited, Medic Biologicals and Pharmaceuticals Private Limited, Delius Pharmaceuticals Private Limited, Anax Lifescience Private Limited, Curosis Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Jatin Jindal was appointed as Director on 22 Feb 2019. Lata Jindal was appointed as Director on 22 Feb 2019.
Yes, Lxir Medilabs is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0006237).
Lxir Medilabs can be reached through the website lxir.co.in. Its registered office is in Panchkula, Haryana, India.

